Skip to content
CT
Company

Updated:

Cerevel Therapeutics Holdings, Inc.

Cerevel Therapeutics Holdings, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001805387, and its...

Overview

Cerevel Therapeutics Holdings, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001805387, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2024-02-27, it reported annual revenue of USD 0; net income of USD -432,842,000; total assets of USD 1,243,298,000 for the fiscal period ended 2023-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

Company overview

Legal name
Cerevel Therapeutics Holdings, Inc.
Former names in filing history
ARYA Sciences Acquisition Corp II (2020-03-10 to 2020-10-26)
Classification
Company
Industry (SIC)
2834 — Pharmaceutical Preparations
Headquarters
Cambridge, MA, United States
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
0001805387

Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

Fiscal yearPeriod endRevenueNet incomeTotal assetsCash and equivalentsOperating cash flow
FY2023USD$0-$432.8M$1.2B$416.5M-$342.3M
FY2022USD$0-$351.5M$1.0B$136.5M-$293.2M
FY2021USD$0-$225.3M$688.9M$193.0M-$178.5M
FY2020USD$0-$152.1M$445.3M$383.6M-$117.8M

Recent SEC filings

FormFiledPeriodFiling
8-K8-K
10-Q10-Q
10-K/A10-K/A
10-K10-K
8-K8-K
8-K8-K
10-Q10-Q
8-K8-K
8-K8-K
8-K8-K
10-Q10-Q
8-K8-K

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Research Cerevel Therapeutics Holdings, Inc. in Altss

Track this company’s investors, transactions and relationships in Altss.

Book a demo

More Company profiles

Cerevel Therapeutics Holdings, Inc. | Company | Altss